SCHEMBL17309092

SCHEMBL17309092

COCc1cnc(C)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17307631 0.78 PDE1A (0.33)
SCHEMBL4424869 0.75 CCNB2 (0.31)
SCHEMBL2629342 0.75
SCHEMBL15229474 0.73
SCHEMBL22792609 0.73
SCHEMBL873971 0.73
SCHEMBL8566607 0.73
SCHEMBL5833261 0.73
SCHEMBL5540227 0.73
SCHEMBL5535219 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9795608-B2 Protein kinase inhibitors PHARMASCIENCE, INC. (CA) 2017-10-24 US disclosed
EP-2870158-B1 1-[4-(3-PHENOXY)-PHENYL]-1H-PYRAZOLO[4,3-D]PYRIMIDIN-7-YL-AMINE DERIVATIVES AS BRUTON'S TYROSINE KINASE (BTK) INHIBITORS FOR THE TREATMENT OF E.G. PROLIFERATIVE DISEASES PHARMASCIENCE INC (CA) 2017-05-31 EP disclosed
US-9447102-B2 Protein kinase inhibitors PHARMASCIENCE, INC. (CA) 2016-09-20 US disclosed
US-20150344478-A1 PROTEIN KINASE INHIBITORS GB005, INC. 2015-12-03 US disclosed